Trends And Challenges In Outsourced Oral Solid Dosage Forms
Source: Thermo Fisher Scientific
As drug companies have fewer and fewer new compounds entering their R&D pipelines, outsourcing of development and manufacturing activities for oral solid dosage forms and sterile forms is on the rise. In a recent podcast, Anil Kane, Ph.D., MBA, Global Head of Technical and Scientific Affairs of Formulation at Patheon, discussed trends and significant changes in outsourcing the manufacture and development of solid oral dosage forms.
access the Q&A!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Thermo Fisher Scientific
This website uses cookies to ensure you get the best experience on our website. Learn more